Fig. 10
From: Neuromodulation by nanozymes and ultrasound during Alzheimer’s disease management
A Schematic Chart of Pd@PEG@Bor Synthesis and Schematic Diagram of the Pd@PEG@Bor Mechanism of AD Treatment. Right panel: B Amelioration of memory deficits and reduction of Aβ deposits during treatment. Path tracings of different groups in a probe trial. C Open-field test involving the numbers of the crossing grid, rearing, and defecation. D Latency time of each group in hidden platform learning. E Time spent on the target quadrant in a probe trial. F Representative images of amyloid plaques stained by the immunofluorescence technique in the cortex region from AD mice (scale bar = 50 μm). Aβ1–42-stained plaques (red); DAPI (blue) [121]. Reproduced with permission copyright 2021, American Chemical Society